211At-methlene blue for targeted radiotherapy of disseminated melanoma: Microscopic analysis of tumour versus normal tissue damage

European Journal of Cancer Part A

Volumn 32, Issue 11, 1996, Pages 1986-1994

  Link, E M ^a   Michalowski, A S ^b   Rosch F ^c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

Astatine 211; Melanoma; Radiation damage; Radiolabelled methylene blue; Targeted radiotherapy; particles

Indexed keywords

METHYLENE BLUE; PIGMENT; RADIOISOTOPE; ASTATINE; DRUG CARRIER;

ALPHA RADIATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTOPENIA; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; TUMOR XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; LYMPH NODE; NUDE MOUSE; PATHOLOGY; RADIATION EXPOSURE; RADIOTHERAPY; SKIN TUMOR; THYROID GLAND; XENOGRAFT;

ANIMALS; ASTATINE; DRUG CARRIERS; FEMALE; HUMANS; LYMPH NODES; MELANOMA; METHYLENE BLUE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RADIATION INJURIES; RADIOTHERAPY; SKIN NEOPLASMS; THYROID GLAND; TRANSPLANTATION, HETEROLOGOUS;

EID: 0030272264     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00236-5     Document Type: Article

References (24)

1. 1. MacKie RM, Aitchison T, Sirel JM, McLaren K, Watt DC. Prognostic models for subgroups of melanoma patients from the Scottish Melanoma Group database 1979-86 and their subsequent validation. Br J Cancer 1995, 71, 173-176.
2. 211At-methylene blue. In Amaldi U, Larsson B, eds. Hadron Therapy in Oncology, Excerpta Medica, International Congress Series 1077, Elsevier, 1994, 677-680.
3. 3. Potts AM. The reaction of uveal pigment in vitro with polycyclic compounds. Invest Opthalmol Vis Sci 1964, 3, 405-416.
4. 4. Forrest IS, Gutmann F, Keyzer H. In vitro interaction of chlorpromazine and melanin. Rev Agress 1966, VII, 147-152.
5. 5. Foster R, Hanson P. Electron-donor-acceptor complex formation by compounds of biological interest. I. Optical absorption spectra of mixtures of phenothiazines and related compounds with electron acceptors. Biochim Biophys Acta 1966, 112, 482-489.
6. 6. Foster R, Fyfe CA. Electron-donor-acceptor complex formation by compounds of biological interest. II. The association-constant of various 1,4-dinitrobenzene-phenothiazine drug complexes. Biochim Biophys Acta 1966, 112, 490-495.
7. 7. Larsson B, Tjälve H. Studies on the mechanism of drug binding to melanin. Biochem Pharmacol 1979, 28, 1181-1187.
8. 8. Link EM, Lukiewicz S. A new radioactive drug selectively accumulating in melanoma cells. Eur J Nucl Med 1982, 7, 469-473.
9. 211At-methylene blue for pigmented melanoma in an animal model system. Cancer Res 1989, 49, 4332-4337.
10. 10. Link EM, Rydzy M. Endoirradiation of neoplastic tissues by administered radioisotopes. In Proceedings of the Third Meeting of the Polish Biophysics Society, 1978, 62.
11. 11. Link EM, Costa DC, Lui D, Ell PJ, Blower PJ, Spittle MF. Targeting disseminated melanoma with radiolabelled methylene blue: comparative biodistribution studies in man and animals. Acta Oncol 1996, 35, 331-341.
12. 12. Humm JL. Dosimetric aspects of radiolabelled antibodies for tumour therapy. J Nucl Med 1986, 27, 422-427.
13. 13. Kassis AI, Harris CR, Adelstein SJ, Ruth TJ, Lambrecht R, Wolf AP. The in vitro radiobiology of astatine-211 decay. Radiat Res 1986, 105, 27-36.
14. 14. Hall EJ. Linear energy transfer and relative biological effectiveness. In Radiobiology for the Radiologist, IVth edn. Philadelphia, Lippincott, 1994, 153-164.
15. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of micrometastases. Cancer Res 1990, 50, 2963-2967.
16. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: treatment of cutaneous tumors and lymph node metastases. Cancer Res 1992, 52, 4385-4390.
17. 211At-methylene blue for targeted radiotherapy of human melanoma xenografts: dose fractionation in the treatment of cutaneous tumours. Eur J Cancer 1996, 32A, 1240-1247.
18. 18. Thomas JM. A lung colony clonogenic cell assay from human malignant melanoma in immune-suppressed mice and its use to determine chemosensitivity, radiosensitivity and the relationship between tumour size and response to therapy. Br J Surg 1979, 66, 696-700.
19. 19. West CML, Sandhu RR, Stratford IJ. The radiation response of V79 and human tumour multicellular spheroids-cell survival and growth delay studies. Br J Cancer 1984, 50, 143-151.
20. 211At. J Radioanal Nucl Chem Lett 1985, 96, 319-332.
21. 21. Baker FJ, Silverton RE, eds. Introduction to Medical Laboratory Technology. Butterworth Scientific, London, 1976, 299-426.
22. 22. Cobb LM, Harrison A, Butler SA. Toxicology of astatine-211 in the mouse. Hum Toxicol 1988, 7, 529-534.
23. 23. Dubois D, Ledermann JA, Link EM, Stauss H, Collins M. Malignant melanoma. Lancet 1992, 340, 948-951.
24. 24. Shaffer RN. Alpha radiation. Effect of astatine-211 on the anterior segment and on an epithelial cyst. Trans Am Ophthalmol Soc 1952, 50, 607-627.